US Trade Representative Jamieson Greer has launched an investigation against Germany under Section 301 of Trade Act over alleged underpayment for innovative pharmaceuticals, a move that could lead to trade measures. 
US Trade Representative Jamieson Greer has launched an investigation against Germany under Section 301 of Trade Act over alleged underpayment for innovative pharmaceuticals, a move that could lead to trade measures. 
<iframe src="https://hindustansphere.com/embed/cluster/966b3db324be9427017a4516d54655f69bf1c9a3" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="US launches tariff probe against Germany under Section 301 over drug pricing | What does it mean for Berlin?"></iframe>
US Trade Representative Jamieson Greer has launched an investigation against Germany under Section 301 of Trade Act over alleged underpayment for innovative pharmaceuticals, a move that could lead to trade measures.&nbsp;
